; and (I) the manufacturer marketed or sold a follow-on product. (ii) (I) The manufacturer of the listed drug or reference product— (aa) withdrew, discontinued the manufacture of, or withdrew the application with respect to, or announced withdrawal of, discontinuance of the manufacture of, or withdrawal of the application with respect to, the drug or reference product in a manner that impedes competition from a generic drug or a biosimilar biological product, as established by objective circumstances, unless such actions were taken by the manufacturer pursuant to a request of the Commissioner of Food and Drugs; or (bb) destroyed the inventory of the listed drug or reference product in a manner that impedes competition from a generic drug or a biosimilar biological product, which may be established by objective circumstances